Announcements Trials
Browse Landscape

Phase

Phase 2 26Phase 3 11Phase 1/2 9Phase 1 5Phase NA 1Phase 4 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Recurrence 1Lymphoma, Mantle-Cell 1Lymphatic Diseases 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, B-Cell 1Heart Failure 1

Interventions

Rituximab 4Cyclophosphamide 4pirtobrutinib 3fludarabine 2Chlorambucil 2venetoclax 1ofatumumab 1idelalisib 1ibrutinib 1fludarabine phosphate 1acalabrutinib 1Valganciclovir 1Thiotepa 1Sirolimus 1Radiotherapy 1Prednisone 1Pneumococcal Vaccines 1Pentostatin 1Filgrastim 1Everolimus 1Biopsy, Needle 1Bendamustine Hydrochloride 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Leukemia, Lymphocytic, Chronic, B-Cell × acalabrutinib × Clear all
NCT04930536 2024-11-22

Acalabrutinib Study in Indian Patients With Chronic Lymphocytic Leukaemia & Relapsed and Refractory Mantle Cell Lymphoma

AstraZeneca

Phase 4 Completed
103 enrolled 10 charts
LymphoidOther hematologic neoplasm

Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡